Filing Details

Accession Number:
0000904454-13-000492
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-17 17:14:35
Reporting Period:
2013-04-15
Filing Date:
2013-04-17
Accepted Time:
2013-04-17 17:14:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333248 Cadence Pharmaceuticals Inc CADX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013425 I Jesse Treu C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1024000 C James Blair C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
Yes No Yes No
1196863 Nicole Vitullo C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1207786 H Brian Dovey C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1207789 K Kathleen Schoemaker C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
1298033 Domain Partners Vi, L.p. C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-04-15 71,578 $6.62 7,313,241 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.
  2. The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
  3. As managing members of Domain Associates, LLC, each Reporting Owner listed below may also be deemed to indirectly beneficially own 27,500 shares of Common Stock held by Domain Associates, LLC.
  4. As managing members of the respective sole general partners of DP VII Associates, L.P., Domain Partners VII, L.P. and DP VI Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by each such entity as follows: 40,484 shares held by DP VII Associates, L.P., 2,371,190 shares held by Domain Partners VII, L.P. and 78,369 shares held by DP VI Associates, L.P.